National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 3) (PB 27 of 2017) (Cth)

Case

PB 27 of 2017

National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 3)

National Health Act 1953

I, LOUISE CLARKE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 27 April 2017

LOUISE CLARKE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 3).

(2)        This Instrument may also be cited as PB 27 of 2017.

2          Commencement

This Instrument commences on 1 May 2017.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1]Schedule 1, entry for Alendronic acid with colecalciferol in the form Tablet 70 mg
(as alendronate sodium) with 70 micrograms colecalciferol

(a)   omit from the column headed “Determined Price”:             4.06        substitute:             3.64

(b)   omit from the column headed “Claimed Price”:                  8.02        substitute:             7.19

[2]Schedule 1, entry for Alendronic acid with colecalciferol in the form Tablet 70 mg
(as alendronate sodium) with 140 micrograms colecalciferol [Brand: Dronalen Plus]

(a)   omit from the column headed “Determined Price”:             4.06        substitute:             3.64

(b)   omit from the column headed “Claimed Price”:                  6.02        substitute:             5.40

[3]Schedule 1, entry for Alendronic acid with colecalciferol in the form Tablet 70 mg
(as alendronate sodium) with 140 micrograms colecalciferol [Brand: Fosamax Plus 70 mg/140 mcg]

(a)   omit from the column headed “Determined Price”:             4.06        substitute:             3.64

(b)   omit from the column headed “Claimed Price”:                  8.02substitute:             7.19

[4]Schedule 1, entry for Alendronic acid with colecalciferol and calcium
[Brand: Dronalen Plus D-Cal]

(a)   omit from the column headed “Determined Price”:             4.06        substitute:             3.64

(b)   omit from the column headed “Claimed Price”:                  10.02substitute:             8.98

[5]Schedule 1, entry for Alendronic acid with colecalciferol and calcium
[Brand: Fosamax Plus D-Cal]

(a)   omit from the column headed “Determined Price”:             4.06        substitute:             3.64

(b)   omit from the column headed “Claimed Price”:                  12.02substitute:             10.78

[6]Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)

(a)   omit from the column headed “Determined Price”:             1.00        substitute:             0.83

(b)   omit from the column headed “Claimed Price”:                  9.10substitute:             7.55

[7]Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)

(a)   omit from the column headed “Determined Price”:             1.76        substitute:             1.47

(b)   omit from the column headed “Claimed Price”:                  9.85substitute:             8.23

[8]Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg

(a)   omit from the column headed “Determined Price”:             8.33        substitute:             7.15

(b)   omit from the column headed “Claimed Price”:                  12.94substitute:             11.11

[9]Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

(a)   omit from the column headed “Determined Price”:             10.41     substitute:             8.94

(b)   omit from the column headed “Claimed Price”:                  15.01substitute:             12.89

  1. Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate
    10 mg

(a)   omit from the column headed “Determined Price”:             13.01     substitute:             11.17

(b)   omit from the column headed “Claimed Price”:                  17.61substitute:             15.12

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

(a)   omit from the column headed “Determined Price”:             0.61        substitute:             0.43

(b)   omit from the column headed “Claimed Price”:                  2.47substitute:             1.74

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

(a)   omit from the column headed “Determined Price”:             1.81        substitute:             1.29

(b)   omit from the column headed “Claimed Price”:                  3.75substitute:             2.67

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

(a)   omit from the column headed “Determined Price”:             5.42        substitute:             3.84

(b)   omit from the column headed “Claimed Price”:                  7.28substitute:             5.16

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

(a)   omit from the column headed “Determined Price”:             6.56        substitute:             4.64

(b)   omit from the column headed “Claimed Price”:                  12.72substitute:             9.00

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

(a)   omit from the column headed “Determined Price”:             6.29        substitute:             4.12

(b)   omit from the column headed “Claimed Price”:                  8.15substitute:             5.34

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

(a)   omit from the column headed “Determined Price”:             7.48        substitute:             4.82

(b)   omit from the column headed “Claimed Price”:                  13.89substitute:             8.95

  1. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

(a)   omit from the column headed “Determined Price”:             8.05        substitute:             5.59

(b)   omit from the column headed “Claimed Price”:                  14.73substitute:             10.23

  1. Schedule 1, entry for Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             3.60        substitute:             2.98

(b)   omit from the column headed “Claimed Price”:                  5.55substitute:             4.59

  1. Schedule 1, entry for Ciprofloxacin in the form Tablet 500 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             7.03        substitute:             5.82

(b)   omit from the column headed “Claimed Price”:                  9.76substitute:             8.08

  1. Schedule 1, entry for Clindamycin

(a)   omit from the column headed “Determined Price”:             7.87        substitute:             6.39

(b)   omit from the column headed “Claimed Price”:                  15.40substitute:             12.50

  1. Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg

(a)   omit from the column headed “Determined Price”:             1.56        substitute:             1.37

(b)   omit from the column headed “Claimed Price”:                  3.16substitute:             2.78

  1. Schedule 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg

(a)   omit from the column headed “Determined Price”:             2.17        substitute:             1.91

(b)   omit from the column headed “Claimed Price”:                  5.38substitute:             4.74

  1. Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)

(a)   omit from the column headed “Determined Price”:             2.35        substitute:             1.95

(b)   omit from the column headed “Claimed Price”:                  9.85substitute:             8.17

  1. Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)

(a)   omit from the column headed “Determined Price”:             2.38        substitute:             1.97

(b)   omit from the column headed “Claimed Price”:                  10.19substitute:             8.43

  1. Schedule 1, entry for Exemestane

(a)   omit from the column headed “Determined Price”:             58.26     substitute:             51.62

(b)   omit from the column headed “Claimed Price”:                  61.06substitute:             54.10

  1. Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)

(a)   omit from the column headed “Determined Price”:             3.00        substitute:             2.61

(b)   omit from the column headed “Claimed Price”:                  5.23substitute:             4.55

  1. Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)

(a)   omit from the column headed “Determined Price”:             4.32        substitute:             3.75

(b)   omit from the column headed “Claimed Price”:                  6.55substitute:             5.69

  1. Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)

(a)   omit from the column headed “Determined Price”:             7.82        substitute:             6.79

(b)   omit from the column headed “Claimed Price”:                  10.05substitute:             8.73

  1. Schedule 1, entry for Fluoxetine in each of the forms: Capsule 20 mg (as hydrochloride); and Tablet, dispersible, 20 mg
    (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             3.98        substitute:             3.45

(b)   omit from the column headed “Claimed Price”:                  5.25substitute:             4.55

  1. Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 250 micrograms (anhydrous) in 1 mL single dose units, 30

(a)   omit from the column headed “Determined Price”:             8.71        substitute:             7.55

(b)   omit from the column headed “Claimed Price”:                  8.94substitute:             7.75

  1. Schedule 1, entry for Ipratropium in the form Nebuliser solution containing ipratropium bromide 500 micrograms (anhydrous) in 1 mL single dose units, 30

(a)   omit from the column headed “Determined Price”:             10.29     substitute:             8.92

(b)   omit from the column headed “Claimed Price”:                  10.52substitute:             9.12

  1. Schedule 1, entry for Isosorbide Mononitrate in the form Tablet 120 mg (sustained release)

(a)   omit from the column headed “Determined Price”:             7.61        substitute:             6.81

(b)   omit from the column headed “Claimed Price”:                  10.74substitute:             9.61

  1. Schedule 1, entry for Lamotrigine in the form Tablet 25 mg

(a)   omit from the column headed “Determined Price”:             6.38        substitute:             5.18

(b)   omit from the column headed “Claimed Price”:                  8.23substitute:             6.68

  1. Schedule 1, entry for Lamotrigine in the form Tablet 50 mg

(a)   omit from the column headed “Determined Price”:             10.64     substitute:             8.63

(b)   omit from the column headed “Claimed Price”:                  12.29substitute:             9.97

  1. Schedule 1, entry for Lamotrigine in the form Tablet 100 mg

(a)   omit from the column headed “Determined Price”:             17.71     substitute:             14.37

(b)   omit from the column headed “Claimed Price”:                  19.43substitute:             15.77

  1. Schedule 1, entry for Lamotrigine in the form Tablet 200 mg

(a)   omit from the column headed “Determined Price”:             29.77     substitute:             24.15

(b)   omit from the column headed “Claimed Price”:                  31.49substitute:             25.54

  1. Schedule 1, entry for Lisinopril in the form Tablet 5 mg

(a)   omit from the column headed “Determined Price”:             2.34        substitute:             2.01

(b)   omit from the column headed “Claimed Price”:                  5.41substitute:             4.65

  1. Schedule 1, entry for Lisinopril in the form Tablet 10 mg

(a)   omit from the column headed “Determined Price”:             3.50        substitute:             3.01

(b)   omit from the column headed “Claimed Price”:                  6.57substitute:             5.65

  1. Schedule 1, entry for Lisinopril in the form Tablet 20 mg

(a)   omit from the column headed “Determined Price”:             4.41        substitute:             3.79

(b)   omit from the column headed “Claimed Price”:                  7.48substitute:             6.43

  1. Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg

(a)   omit from the column headed “Determined Price”:             3.23        substitute:             2.60

(b)   omit from the column headed “Claimed Price”:                  5.55substitute:             4.47

  1. Schedule 1, entry for Meloxicam in the form Capsule 15 mg

(a)   omit from the column headed “Determined Price”:             4.71        substitute:             3.80

(b)   omit from the column headed “Claimed Price”:                  7.03substitute:             5.67

  1. Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg

(a)   omit from the column headed “Determined Price”:             3.23        substitute:             2.60

(b)   omit from the column headed “Claimed Price”:                  5.55substitute:             4.47

  1. Schedule 1, entry for Meloxicam in the form Tablet 15 mg

(a)   omit from the column headed “Determined Price”:             4.71        substitute:             3.80

(b)   omit from the column headed “Claimed Price”:                  7.03substitute:             5.67

  1. Schedule 1, entry for Mirtazapine in the form Tablet 15 mg (orally disintegrating)
    [Brands: Avanza SolTab; Remeron SolTab]

(a)   omit from the column headed “Determined Price”:             4.52        substitute:             3.85

(b)   omit from the column headed “Claimed Price”:                  8.24substitute:             7.02

  1. Schedule 1, entry for Mirtazapine in the form Tablet 30 mg

(a)   omit from the column headed “Determined Price”:             3.93        substitute:             3.35

(b)   omit from the column headed “Claimed Price”:                  7.19substitute:             6.13

  1. Schedule 1, entry for Mirtazapine in the form Tablet 30 mg (orally disintegrating)
    [Brands: Avanza SolTab; Remeron SolTab]

(a)   omit from the column headed “Determined Price”:             6.02        substitute:             5.13

(b)   omit from the column headed “Claimed Price”:                  9.74substitute:             8.30

  1. Schedule 1, entry for Mirtazapine in the form Tablet 45 mg

(a)   omit from the column headed “Determined Price”:             6.55        substitute:             5.58

(b)   omit from the column headed “Claimed Price”:                  9.80substitute:             8.35

  1. Schedule 1, entry for Mirtazapine in the form Tablet 45 mg (orally disintegrating)
    [Brands: Avanza SolTab; Remeron SolTab]

(a)   omit from the column headed “Determined Price”:             9.07        substitute:             7.72

(b)   omit from the column headed “Claimed Price”:                  12.79substitute:             10.89

  1. Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g

(a)   omit from the column headed “Determined Price”:             3.85        substitute:             3.08

(b)   omit from the column headed “Claimed Price”:                  6.36substitute:             5.09

  1. Schedule 1, entry for Mometasone in the form Lotion containing mometasone furoate 1 mg per g, 30 mL

(a)   omit from the column headed “Determined Price”:             6.07        substitute:             4.86

(b)   omit from the column headed “Claimed Price”:                  8.58substitute:             6.87

  1. Schedule 1, entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g

(a)   omit from the column headed “Determined Price”:             3.85        substitute:             3.08

(b)   omit from the column headed “Claimed Price”:                  6.36substitute:             5.09

  1. Schedule 1, entry for Montelukast

(a)   omit from the column headed “Determined Price”:             8.50        substitute:             6.65

(b)   omit from the column headed “Claimed Price”:                  10.36substitute:             8.11

  1. Schedule 1, entry for Nifedipine in the form Tablet 20 mg

(a)   omit from the column headed “Determined Price”:             6.40        substitute:             5.71

(b)   omit from the column headed “Claimed Price”:                  8.79substitute:             7.84

  1. Schedule 1, entry for Nifedipine in the form Tablet 30 mg (controlled release)

(a)   omit from the column headed “Determined Price”:             7.19        substitute:             6.41

(b)   omit from the column headed “Claimed Price”:                  9.81substitute:             8.75

  1. Schedule 1, entry for Nifedipine in the form Tablet 60 mg (controlled release)

(a)   omit from the column headed “Determined Price”:             9.03        substitute:             8.05

(b)   omit from the column headed “Claimed Price”:                  11.81substitute:             10.53

  1. Schedule 1, entry for Omeprazole

(a)   omit from the column headed “Determined Price”:             4.74        substitute:             4.12

(b)   omit from the column headed “Claimed Price”:                  7.59substitute:             6.60

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besylate)

(a)   omit from the column headed “Determined Price”:             4.17        substitute:             4.00

(b)   omit from the column headed “Claimed Price”:                  8.77substitute:             8.41

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besylate)

(a)   omit from the column headed “Determined Price”:             4.93        substitute:             4.64

(b)   omit from the column headed “Claimed Price”:                  9.53substitute:             8.97

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besylate)

(a)   omit from the column headed “Determined Price”:             5.85        substitute:             5.68

(b)   omit from the column headed “Claimed Price”:                  10.45substitute:             10.15

  1. Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besylate)

(a)   omit from the column headed “Determined Price”:             6.61        substitute:             6.32

(b)   omit from the column headed “Claimed Price”:                  11.22substitute:             10.73

  1. Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium
    10 mg

(a)   omit from the column headed “Determined Price”:             1.72        substitute:             1.43

(b)   omit from the column headed “Claimed Price”:                  5.02substitute:             4.17

  1. Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium
    20 mg

(a)   omit from the column headed “Determined Price”:             2.73        substitute:             2.27

(b)   omit from the column headed “Claimed Price”:                  6.04substitute:             5.02

  1. Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium
    40 mg

(a)   omit from the column headed “Determined Price”:             4.24        substitute:             3.53

(b)   omit from the column headed “Claimed Price”:                  7.60substitute:             6.33

  1. Schedule 1, entry for Pravastatin in the form Tablet containing pravastatin sodium
    80 mg

(a)   omit from the column headed “Determined Price”:             6.52        substitute:             5.43

(b)   omit from the column headed “Claimed Price”:                  9.88substitute:             8.23

  1. Schedule 1, entry for Quinapril in the form Tablet 10 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             4.16        substitute:             3.71

(b)   omit from the column headed “Claimed Price”:                  7.60substitute:             6.78

  1. Schedule 1, entry for Quinapril in the form Tablet 20 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             5.14        substitute:             4.58

(b)   omit from the column headed “Claimed Price”:                  8.58substitute:             7.65

  1. Schedule 1, entry for Ranitidine in each of the forms: Tablet 150 mg (as hydrochloride); and Tablet 300 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             3.85        substitute:             3.22

(b)   omit from the column headed “Claimed Price”:                  6.14substitute:             4.78

  1. Schedule 1, entry for Ranitidine in the form Tablet, effervescent, 150 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             2.17        substitute:             1.81

(b)   omit from the column headed “Claimed Price”:                  2.82substitute:             2.35

  1. Schedule 1, entry for Sertraline in each of the forms: Tablet 50 mg (as hydrochloride); and Tablet 100 mg (as hydrochloride)

(a)   omit from the column headed “Determined Price”:             1.86        substitute:             1.57

(b)   omit from the column headed “Claimed Price”:                  6.77substitute:             5.71

  1. Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride
    80 mg

(a)   omit from the column headed “Determined Price”:             3.41        substitute:             2.99

(b)   omit from the column headed “Claimed Price”:                  7.99substitute:             7.01

  1. Schedule 1, entry for Sotalol in the form Tablet containing sotalol hydrochloride
    160 mg

(a)   omit from the column headed “Determined Price”:             7.32        substitute:             6.43

(b)   omit from the column headed “Claimed Price”:                  11.90substitute:             10.45

  1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-5 mg
    (as besylate)

(a)   omit from the column headed “Determined Price”:             3.43        substitute:             3.27

(b)   omit from the column headed “Claimed Price”:                  5.93substitute:             5.65

  1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 40 mg-10 mg
    (as besylate)

(a)   omit from the column headed “Determined Price”:             4.14        substitute:             3.87

(b)   omit from the column headed “Claimed Price”:                  6.64substitute:             6.21

  1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-5 mg
    (as besylate)

(a)   omit from the column headed “Determined Price”:             8.17        substitute:             8.01

(b)   omit from the column headed “Claimed Price”:                  10.67substitute:             10.46

  1. Schedule 1, entry for Telmisartan with amlodipine in the form Tablet 80 mg-10 mg
    (as besylate)

(a)   omit from the column headed “Determined Price”:             8.88        substitute:             8.61

(b)   omit from the column headed “Claimed Price”:                  11.38substitute:             11.03

  1. Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 40 mg-12.5 mg

(a)   omit from the column headed “Determined Price”:             3.67        substitute:             2.12

(b)   omit from the column headed “Claimed Price”:                  5.67substitute:             3.28

  1. Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-12.5 mg

(a)   omit from the column headed “Determined Price”:             8.65        substitute:             5.29

(b)   omit from the column headed “Claimed Price”:                  10.65substitute:             6.51

  1. Schedule 1, entry for Telmisartan with hydrochlorothiazide in the form Tablet 80 mg-25 mg

(a)   omit from the column headed “Determined Price”:             9.94        substitute:             5.76

(b)   omit from the column headed “Claimed Price”:                  11.94substitute:             6.92

  1. Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg

(a)   omit from the column headed “Determined Price”:             2.53        substitute:             2.24

(b)   omit from the column headed “Claimed Price”:                  6.71substitute:             5.94

  1. Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg

(a)   omit from the column headed “Determined Price”:             3.40        substitute:             3.00

(b)   omit from the column headed “Claimed Price”:                  8.40substitute:             7.41

  1. Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg

(a)   omit from the column headed “Determined Price”:             4.14        substitute:             3.66

(b)   omit from the column headed “Claimed Price”:                  9.79substitute:             8.66

  1. Schedule 1, entry for Trimethoprim with Sulfamethoxazole in the form Tablet 160 mg-800 mg

(a)   omit from the column headed “Determined Price”:             2.28        substitute:             1.76

(b)   omit from the column headed “Claimed Price”:                  7.31substitute:             5.64

  1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 10]

(a)   omit from the column headed “Determined Price”:             6.37        substitute:             5.24

(b)   omit from the column headed “Claimed Price”:                  7.89substitute:             6.49

  1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 30]

omit from the column headed “Claimed Price”:   22.14substitute:             18.21

  1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 42]

omit from the column headed “Claimed Price”:   29.78substitute:             24.50

  1. Schedule 1, entry for Valaciclovir [Pricing Quantity/Pack Quantity: 100]

omit from the column headed “Claimed Price”:   64.33substitute:             52.92

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0